MedPath

dHACM in Lumbar Decompression and Microdiscectomy Surgery

Not Applicable
Completed
Conditions
Spinal Stenosis
Scarring
Herniated Disc
Interventions
Procedure: Lumbar Decompression Surgery
Procedure: Microdiscectomy Surgery
Other: Dehydrated Human Amnion/Chorion Membrane (dHACM)
Registration Number
NCT02300909
Lead Sponsor
MiMedx Group, Inc.
Brief Summary

Prospective evaluation of the safety and efficacy of dHACM on clinical outcomes in lumbar laminectomy and microdiscectomy patients as assessed by Oswestry Disability Index.

Detailed Description

The objective of this prospective study is to evaluate the safety and efficacy of dHACM on clinical outcomes in lumbar laminectomy and microdiscectomy patients randomized to one of two groups: 1) without dHACM (control) or 2) dHACM.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
143
Inclusion Criteria
  1. Are 18 (eighteen) years of age or older at the time of surgery.
  2. Patients with single- or multi-level spinal stenosis undergoing open lumbar laminectomy, or patients with single-level herniated nucleus pulposus undergoing single-level lumbar microdiscectomy
  3. Are willing and able to return for the scheduled follow-up visits, follow post operative instructions and undergo the required radiographic exams for up to 5 time points between 4 weeks and 24 months post-surgery (6 weeks ± 2 weeks, 12 weeks ± 2 weeks, 6 months ±1 month, 1 year±2 months, and 2 years ±2 months post-surgery), including one study MRI-scan at 12 weeks ±2 weeks for the first 20 patients enrolled.
  4. Are willing and able to sign study specific informed consent.
Exclusion Criteria
  1. Non-English speaking patients
  2. Non-surgical candidate defined as any patient deemed by the surgeon not to be a surgical candidate cannot participate for the following reasons: that patient does not meet indications for lumbar laminectomy or microdiscectomy surgery, patient has a contraindication to surgery such as medical comorbidities, pregnancy, etc.
  3. Allergic to aminoglycoside antibiotics
  4. Is a prisoner
  5. Is involved in worker's compensation or other litigation relative to the spine injury
  6. Has a history of drug or alcohol abuse within the last 12 months
  7. Is currently participating in another drug or device clinical trial
  8. Previous spinal surgery
  9. History of deformity, mechanical instability, or spinal fusion requirement
  10. History of hard- or soft-tissue spinal infection
  11. Has signs or symptoms of any disease, such as autoimmune disease, which could result in allograft failure, or has experienced allograft failure in the past
  12. Patients unable to undergo a MRI

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Surgery without dHACMMicrodiscectomy SurgeryControl Group - Lumbar Decompression Surgery or Microdiscectomy Surgery without application of dHACM
dHACMMicrodiscectomy SurgeryLumbar Decompression Surgery or Microdiscectomy Surgery with Application of Dehydrated Human Amnion/Chorion Membrane (dHACM)
dHACMLumbar Decompression SurgeryLumbar Decompression Surgery or Microdiscectomy Surgery with Application of Dehydrated Human Amnion/Chorion Membrane (dHACM)
dHACMDehydrated Human Amnion/Chorion Membrane (dHACM)Lumbar Decompression Surgery or Microdiscectomy Surgery with Application of Dehydrated Human Amnion/Chorion Membrane (dHACM)
Surgery without dHACMLumbar Decompression SurgeryControl Group - Lumbar Decompression Surgery or Microdiscectomy Surgery without application of dHACM
Primary Outcome Measures
NameTimeMethod
Oswestry Disability Index2 years

Patient Functional Outcomes Questionnaire

Secondary Outcome Measures
NameTimeMethod
Quality of Life (SF-36)2 years

SF-36

Re-operation (Number of patients having re-operation during study)2 years

Number of patients having re-operation during study

Quality of Life (VAS Pain)2 years

VAS Pain

Scar formation in revision cases2 years

Dissection of scar formation required at re-operation

Quality of Life2 years

HSS Lumbar Expectations Survey

Trial Locations

Locations (1)

Hospital for Special Surgery

🇺🇸

New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath